Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Bought by Thurston Springer Miller Herd & Titak Inc.

Thurston Springer Miller Herd & Titak Inc. boosted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 8.2% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 5,464 shares of the real estate investment trust’s stock after acquiring an additional 414 shares during the quarter. Thurston Springer Miller Herd & Titak Inc.’s holdings in Omega Healthcare Investors were worth $222,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in OHI. Daiwa Securities Group Inc. boosted its holdings in shares of Omega Healthcare Investors by 1,030.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares during the last quarter. Marshall Wace LLP purchased a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at $20,962,000. BROOKFIELD Corp ON acquired a new position in Omega Healthcare Investors during the 1st quarter worth about $16,446,000. Vanguard Group Inc. increased its stake in Omega Healthcare Investors by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 35,214,682 shares of the real estate investment trust’s stock worth $1,079,682,000 after purchasing an additional 346,811 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after buying an additional 272,299 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Scotiabank raised their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Mizuho cut Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price target for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Wells Fargo & Company restated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Truist Financial raised their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Finally, BMO Capital Markets boosted their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Eight research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Omega Healthcare Investors presently has a consensus rating of “Hold” and an average price target of $37.00.

Omega Healthcare Investors Stock Up 0.4 %

Shares of NYSE:OHI opened at $39.96 on Tuesday. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $41.53. The stock’s 50-day moving average price is $39.43 and its two-hundred day moving average price is $35.02. The firm has a market cap of $9.87 billion, a price-to-earnings ratio of 36.00, a PEG ratio of 1.28 and a beta of 1.00. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm had revenue of $252.70 million for the quarter, compared to analysts’ expectations of $205.92 million. During the same quarter in the previous year, the firm posted $0.74 EPS. The firm’s revenue for the quarter was up 17.5% compared to the same quarter last year. On average, research analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Monday, August 5th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a yield of 6.71%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 241.44%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.